OurMED D8.3.1 Business Models and Exploitation Pathways. Version 1.3
Deliverable 8.3.1 (D8.3.1) aims to define and structure effective business models and exploitation pathways that ensure the successful uptake of OurMED services and products beyond the project’s lifetime. It provides partners with practical knowledge on financial instruments, governance mechanisms, and risk mitigation strategies that can accelerate the commercialization, policy uptake, and long-term sustainability of project outcomes.
Institutions
- Helmholtz Centre for Environmental Research (DE)
- University of Évora (PT)
- AgroParisTech (FR)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-10-13
- DOI
- https://doi.org/10.5281/zenodo.17340854
- Primary Topic
- Life Cycle Costing Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00